Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

The biosimilars reach the US market as the US insulin space has seen seismic changes in the last few years, with a clamour of ...

Merilog’s approval comes as the insulin space has over the past year suffered several setbacks, including strong calls for ...

Patrik Jonsson is an executive vice president at Eli Lilly and president of Lilly Cardiometabolic Health.Courtesy Eli Lilly; Getty Images; BI Illustration Eli Lilly makes the popular shots ...

Still, it requires a special injector pen and consistent refrigeration. Patients also reported uncomfortable side effects from Ozempic, like nausea, vomiting, and diarrhea. Eli Lilly hopes that a ...

Novo Nordisk has made its smart insulin pens available in the UK ... The Danish pharma is trying to stay ahead of arch rivals Eli Lilly and Sanofi in an increasingly competitive insulin market ...

Like Eli Lilly and Sanofi, Novo Nordisk has agreed to implement a texting system to assist pharmacists and patients to determine eligibility for low-cost insulin, and alert patients about this low ...

Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of ...

Aspen has a marketing agreement with Eli Lilly for the sale and distribution ... while Saxenda pens also deliver higher doses of 2.4mg and 3mg. Xultophy is a combination of insulin and liraglutide and ...